Cite
HARVARD Citation
Li, Y. et al. (2022). Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients. Journal of interventional cardiology. p. . [Online].